DEX — Dextech Medical AB Share News
0.000.00%
Last trade - 00:00- SEK189.48m
- SEK180.85m
Brief: DexTech Q4 Operating Profit SEK -1.9 Million
Sweden's DexTech Q3 loss widens, OsteoDex drug study shows favorable safety profile
Brief: DexTech Q3 Operating Profit SEK -1.7 Million
Brief: DexTech Q4 Operating Profit SEK -1.6 Million
Brief: DexTech Q3 Operating Profit SEK -1.3 Million
Brief: DexTech Q4 Operating Profit SEK -1.6 Million
Brief: DexTech Q3 Operating Profit SEK -1.5 Million
Brief: Dextech Medical Announces Positive Results From The Myeloma Study
Brief: Dextech Says Andreas Segerros Proposed As New Chairman Of The Board
Brief: Dextech Medical Q2 Operating Loss Narrows To SEK 1.6 Mln
Brief: DexTech Gets Positive Results Regarding Multiple Myeloma
Brief: DexTech Medical Q4 Operating Loss Narrows To SEK 1.9 Mln
Brief: DexTech: Positive Follow-Up Results In Phase IIb Study For OsteoDex
Brief: Dextech: Phase IIb Study For Osteodex Concludes With Positive Follow-up Results
Brief: DexTech Medical Q3 Operating Loss Narrows To SEK 1.9 Mln
Brief: DexTech To Publish Phase IIb Study For OsteoDex In May
Brief: DexTech Medical Q2 Operating Loss Narrows To SEK 1.9 Mln
Brief: Dextech: Follow-up Results From OsteoDex Study Indicate Prolonged Survival
Brief: DexTech Medical Q4 Pre-Tax Loss Narrows To SEK 2.2 Million